Resmed to sell MatrixCare for $490M to private equity firm

ResMed is divesting its MatrixCare software business to Frazier Healthcare Partners for $490 million to focus resources on higher-growth segments of its medical device portfolio. The transaction reflects strategic portfolio optimization in the health IT and respiratory device sectors.